SPRY2 and breast cancer: By combining in vivo genetic analysis and primary cell culture, we have shown that BC proliferation is actively repressed under steady-state conditions by an FGFR1-SPRY2 signaling axis that functions to inhibit signaling through the ERK and AKT intracellular pathways.